PDF
ePub
Citation
Print
Figures and Tables
Table 1
Individual Risk Factors and the Risk Assessment Profile Score
AIS: Abbreviated injury scale. Data from Greenfield LJ et al. J Trauma 1997;42:100-3.24)
Table 2
Ninth American College of Chest Physicians Guidelines for VTE Prevention (2012)
VTE: Venous thromboembolism, LMWH: Low molecular weight heparin, LDUH: Low-dose unfractionated heparin, IPC: Intermittent pneumatic compression. Data from Kearon C et al. Chest 2012; 141(2 Suppl):e419S-494S.88)
Table 3
Recommendations of the EAST Group for the Venous Thromboembolism Prophylaxis in Trauma Patients (2002)
Level 1: recommendation is justifiable based on the available scientific evidence alone; recommendation is based on class I or a preponderance of class II evidence. Level 2: recommendation is reasonably justifiable based on the available scientific evidence and supported by expert opinion; recommendation is supported by class II evidence or a preponderance of class III evidence. Level 3: recommendation is supported by available data, but inadequate scientific data are available; recommendation is supported by class III evidence. EAST: Eastern Association for the Surgery of Trauma, LDH: Low dose heparin, LMWH: Low molecular weight heparin, ISS: Injury severity score, A-V: Arteriovenous, PCDs: Pneumatic compression devices, VCFs: Vena cava filters. Data from Cushman JG et al. Trauma 2001;51:1016-1026.89)
References
1. Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med. 2010; 38:S502–S509.
2. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007; 44:62–69.
3. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004; 240:490–496. discussion 496-498.
4. Paffrath T, Wafaisade A, Lefering R, et al. Trauma Registry of DGU: Venous thromboembolism after severe trauma: incidence, risk factors and outcome. Injury. 2010; 41:97–101.
5. Chiasson TC, Manns BJ, Stelfox HT. An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med. 2009; 6:e1000098.
6. Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr, Rue LW 3rd. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009; 66:1436–1440.
7. Feliciano DV, Mattox KL, Moore EE. Trauma. 6th ed. New York: McGraw-Hill Medical;2008. p. 1251–1270.
8. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994; 331:1601–1606.
9. Selby R, Geerts W, Ofosu FA, et al. Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism. Thromb Res. 2009; 124:281–287.
10. Eppsteiner RW, Shin JJ, Johnson J, van Dam RM. Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis. World J Surg. 2010; 34:10–19.
11. White RH. The epidemiology of venous thromboembolism. Circulation. 2003; 107:23 Suppl 1. I4–I8.
12. Bendinelli C, Balogh Z. Postinjury thromboprophylaxis. Curr Opin Crit Care. 2008; 14:673–678.
13. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009; 49:2652–2660.
14. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008; 64:1211–1217. discussion 1217.
15. Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients. Br J Surg. 1961; 48:475–489.
16. Datta I, Ball CG, Rudmik L, Hameed SM, Kortbeek JB. Complications related to deep venous thrombosis prophylaxis in trauma: a systematic review of the literature. J Trauma Manag Outcomes. 2010; 4:1.
17. Sase T, Wada H, Kamikura Y, et al. Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases. Thromb Haemost. 2004; 92:132–139.
18. Kudsk KA, Fabian TC, Baum S, Gold RE, Mangiante E, Voeller G. Silent deep vein thrombosis in immobilized multiple trauma patients. Am J Surg. 1989; 158:515–519.
19. Spinella PC, Carroll CL, Staff I, et al. Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries. Crit Care. 2009; 13:R151.
20. Agarwal NK, Mathur N. Deep vein thrombosis in acute spinal cord injury. Spinal Cord. 2009; 47:769–772.
21. Fujii Y, Mammen EF, Farag A, Muz J, Salciccioli GG, Weingarden ST. Thrombosis in spinal cord injury. Thromb Res. 1992; 68:357–368.
22. Do JG, Kim DH, Sung DH. Incidence of deep vein thrombosis after spinal cord injury in Korean patients at acute rehabilitation unit. J Korean Med Sci. 2013; 28:1382–1387.
23. Miranda AR, Hassouna HI. Mechanisms of thrombosis in spinal cord injury. Hematol Oncol Clin North Am. 2000; 14:401–416.
24. Greenfield LJ, Proctor MC, Rodriguez JL, Luchette FA, Cipolle MD, Cho J. Posttrauma thromboembolism prophylaxis. J Trauma. 1997; 42:100–103.
25. Gearhart MM, Luchette FA, Proctor MC, et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery. 2000; 128:631–640.
26. Kitagawa K, Sakoda S. Mechanism underlying thrombus formation in cerebral infarction. Rinsho Shinkeigaku. 2009; 49:798–800.
27. Ruiz AJ, Hill SL, Berry RE. Heparin, deep venous thrombosis, and trauma patients. Am J Surg. 1991; 162:159–162.
28. Seyfer AE, Seaber AV, Dombrose FA, Urbaniak JR. Coagulation changes in elective surgery and trauma. Ann Surg. 1981; 193:210–213.
29. Owings JT, Bagley M, Gosselin R, Romac D, Disbrow E. Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. J Trauma. 1996; 41:396–405. discussion 405-406.
30. Attar S, Boyd D, Layne E, McLaughlin J, Mansberger AR, Cowley RA. Alterations in coagulation and fibrinolytic mechanisms in acute trauma. J Trauma. 1969; 9:939–965.
31. Enderson BL, Chen JP, Robinson R, Maull KI. Fibrinolysis in multisystem trauma patients. J Trauma. 1991; 31:1240–1246.
32. Okamura K, Nakagawa I, Hidaka S, Okada Y, Kubo T, Kato T. Preoperative hypercoagulopathy in patients undergoing orthopedic lower extremity surgery. Masui. 2008; 57:1207–1212.
33. Peetz D, Hafner G, Hansen M, et al. Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-Dimer. Thromb Res. 2000; 98:473–483.
34. Meissner MH, Chandler WL, Elliott JS. Venous thromboembolism in trauma: a local manifestation of systemic hypercoagulability? J Trauma. 2003; 54:224–231.
35. Engelman DT, Gabram SG, Allen L, Ens GE, Jacobs LM. Hypercoagulability following multiple trauma. World J Surg. 1996; 20:5–10.
36. Dries DJ. Activation of the clotting system and complement after trauma. New Horiz. 1996; 4:276–288.
37. Toro JB, Gardner MJ, Hierholzer C, et al. Long-term consequences of pelvic trauma patients with thromboembolic disease treated with inferior vena caval filters. J Trauma. 2008; 65:25–29.
38. Nicolaides AN, Kakkar VV, Field ES, Fish P. Venous stasis and deep-vein thrombosis. Br J Surg. 1972; 59:713–717.
39. Rossi EC, Green D, Rosen JS, Spies SM, Jao JS. Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury. Br J Haematol. 1980; 45:143–151.
40. Myllynen P, Kammonen M, Rokkanen P, et al. The blood F VIII:Ag/F VIII:C ratio as an early indicator of deep venous thrombosis during post-traumatic immobilization. J Trauma. 1987; 27:287–290.
41. Hak DJ. Prevention of venous thromboembolism in trauma and long bone fractures. Curr Opin Pulm Med. 2001; 7:338–343.
42. Cothren CC, Smith WR, Moore EE, Morgan SJ. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg. 2007; 31:98–104.
43. Matthiasson SE, Lindblad B, Bergqvist D. Prevention of experimental venous thrombosis in rabbits with low molecular weight heparin, dextran and their combinations, administered before or during induction of venous endothelial trauma. Thromb Res. 1994; 74:655–663.
44. Becker DM. Venous thromboembolism: epidemiology, diagnosis, prevention. J Gen Intern Med. 1986; 1:402–411.
45. Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002; 53:142–164.
46. Ganzer D, Gutezeit A, Mayer G. Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin. Z Orthop Ihre Grenzgeb. 1999; 137:457–461.
47. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996; 335:701–707.
48. Shackford SR, Davis JW, Hollingsworth-Fridlund P, Brewer NS, Hoyt DB, Mackersie RC. Venous thromboembolism in patients with major trauma. Am J Surg. 1990; 159:365–369.
49. Dennis JW, Menawat S, Von Thron J, et al. Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups. J Trauma. 1993; 35:132–138. discussion 138-139.
50. Upchurch GR Jr, Demling RH, Davies J, Gates JD, Knox JB. Efficacy of subcutaneous heparin in prevention of venous thromboembolic events in trauma patients. Am Surg. 1995; 61:749–755.
51. Napolitano LM, Garlapati VS, Heard SO, et al. Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma. 1995; 39:651–657. discussion 657-659.
52. Arnold JD, Dart BW, Barker DE, et al. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients. Am Surg. 2010; 76:563–570.
53. Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997; 337:688–698.
54. Knudson MM, Lewis FR, Clinton A, Atkinson K, Megerman J. Prevention of venous thromboembolism in trauma patients. J Trauma. 1994; 37:480–487.
55. Schwarcz TH, Quick RC, Minion DJ, Kearney PA, Kwolek CJ, Endean ED. Enoxaparin treatment in high-risk trauma patients limits the utility of surveillance venous duplex scanning. J Vasc Surg. 2001; 34:447–452.
56. Green D, Lee MY, Lim AC, et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med. 1990; 113:571–574.
57. Sems SA, Levy BA, Dajani K, Herrera DA, Templeman DC. Incidence of deep venous thrombosis after temporary joint spanning external fixation for complex lower extremity injuries. J Trauma. 2009; 66:1164–1166.
58. Warwick D. Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between fixed dose and an individually adjusted dose of a low molecular weight heparin. Injury. 1997; 28:233–234.
59. Malinoski D, Jafari F, Ewing T, et al. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma. 2010; 68:874–880.
60. Lu JP, Knudson MM, Bir N, Kallet R, Atkinson K. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study. J Am Coll Surg. 2009; 209:589–594.
61. Turpie AG. The safety of fondaparinux for the prevention and treatment of venous thromboembolism. Expert Opin Drug Saf. 2005; 4:707–721.
62. Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001; 345:1298–1304.
63. Eriksson BI, Lassen MR, Colwell CW Jr. Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients. J Arthroplasty. 2004; 19:7 Suppl 2. 78–81.
64. Rahman A, Colak MC, Ustünel L, Koc M, Kocakoc E, Colak C. A comparison of different treatment managements in patients with acute deep vein thrombosis by the effects on enhancing venous outflow in the lower limb. Med Sci Monit. 2009; 15:CR588–CR593.
65. Xu B. DVT in acute stroke: the use of graduated compression stockings. Aust Fam Physician. 2010; 39:485–487.
66. Arpaia G, Carpenedo M, Pistelli R, Mastrogiacomo O, Cimminiello C, Agnelli G. Attitudes to prescribing compression stockings for patients with acute DVT: the MASTER registry. J Thromb Thrombolysis. 2009; 28:389–393.
67. Sachdeva A, Dalton M, Amaragiri SV, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010; (7):CD001484.
68. Velmahos GC, Nigro J, Tatevossian R, et al. Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient? J Am Coll Surg. 1998; 187:529–533.
69. Gersin K, Grindlinger GA, Lee V, Dennis RC, Wedel SK, Cachecho R. The efficacy of sequential compression devices in multiple trauma patients with severe head injury. J Trauma. 1994; 37:205–208.
70. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis. J Orthop Trauma. 1995; 9:1–7.
71. Kurtoglu M, Yanar H, Bilsel Y, et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg. 2004; 28:807–811.
72. Anglen JO, Bagby C, George R. A randomized comparison of sequential-gradient calf compression with intermittent plantar compression for prevention of venous thrombosis in orthopedic trauma patients: preliminary results. Am J Orthop (Belle Mead NJ). 1998; 27:53–58.
73. Spain DA, Bergamini TM, Hoffmann JF, Carrillo EH, Richardson JD. Comparison of sequential compression devices and foot pumps for prophylaxis of deep venous thrombosis in high-risk trauma patients. Am Surg. 1998; 64:522–525. discussion 525-526.
74. Stannard JP, Lopez-Ben RR, Volgas DA, et al. Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis. J Bone Joint Surg Am. 2006; 88:261–266.
75. Winchell RJ, Hoyt DB, Walsh JC, Simons RK, Eastman AB. Risk factors associated with pulmonary embolism despite routine prophylaxis: implications for improved protection. J Trauma. 1994; 37:600–606.
76. Greenfield LJ, Michna BA. Twelve-year clinical experience with the Greenfield vena caval filter. Surgery. 1988; 104:706–712.
77. Rogers FB, Shackford SR, Ricci MA, Wilson JT, Parsons S. Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism. J Am Coll Surg. 1995; 180:641–647.
78. Rodriguez JL, Lopez JM, Proctor MC, et al. Early placement of prophylactic vena caval filters in injured patients at high risk for pulmonary embolism. J Trauma. 1996; 40:797–802.
79. Shackford SR, Cook A, Rogers FB, Littenberg B, Osler T. The increasing use of vena cava filters in adult trauma victims: data from the American College of Surgeons National Trauma Data Bank. J Trauma. 2007; 63:764–769.
80. Khansarinia S, Dennis JW, Veldenz HC, Butcher JL, Hartland L. Prophylactic Greenfield filter placement in selected high-risk trauma patients. J Vasc Surg. 1995; 22:231–235.
81. Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report: part II: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma. 2000; 49:140–144.
82. Helling TS, Kaswan S, Miller SL, Tretter JF. Practice patterns in the use of retrievable inferior vena cava filters in a trauma population: a single-center experience. J Trauma. 2009; 67:1293–1296.
83. McKenzie S, Gibbs H, Leggett D, et al. An Australian experience of retrievable inferior vena cava filters in patients with increased risk of thromboembolic disease. Int Angiol. 2010; 29:53–57.
84. Gorman PH, Qadri SF, Rao-Patel A. Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury. J Trauma. 2009; 66:707–712.
85. Phelan HA, Gonzalez RP, Scott WC, White CQ, McClure M, Minei JP. Long-term follow-up of trauma patients with permanent prophylactic vena cava filters. J Trauma. 2009; 67:485–489.
86. Rosenthal D, Kochupura PV, Wellons ED, Burkett AB, Methodius-Rayford WC. Günther Tulip and Celect IVC filters in multiple-trauma patients. J Endovasc Ther. 2009; 16:494–499.
87. Cherry RA, Nichols PA, Snavely TM, David MT, Lynch FC. Prophylactic inferior vena cava filters: do they make a difference in trauma patients? J Trauma. 2008; 65:544–548.
88. Kearon C, Akl EA, Comerota AJ, et al. American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141:e419S–e494S.
89. Cushman JG, Agarwal N, Fabian TC, et al. EAST Practice Management Guidelines Work Group. Practice management guidelines for the management of mild traumatic brain injury: the EAST practice management guidelines work group. J Trauma. 2001; 51:1016–1026.
90. Treasure T, Hill J. NICE guidance on reducing the risk of venous thromboembolism in patients admitted to hospital. J R Soc Med. 2010; 103:210–212.
91. Howard LS, Hughes RJ. NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing. Thorax. 2013; 68:391–393.
92. Langford Nj, Stansby G, Avital L. The management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE Guideline CG144. Acute Med. 2012; 11:138–142.
XML Download